okredo logo
none title certification

UAB "Novo Nordisk Pharma" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data
Financial report backgroundFinancial report background mobile

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
14,255,889
716,017
377,747
312,935
15,717
11.89
2.20
554,359
2,413,145
22,068
3,029,446
2022
16,385,375
765,314
637,785
528,683
24,693
13.29
3.23
1,083,042
1,928,036
32,825
3,073,253
2023
21,820,183
935,284
912,567
752,671
32,262
12.00
3.45
1,835,713
4,375,007
35,460
6,332,559
unlock data icon

Register and

explore Okredo data
2023
21,820,183
935,284
912,567
752,671
32,262
12.00
3.45
1,835,713
4,375,007
35,460
6,332,559
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

21,820,183 €Ascended33 % *

Sales per employee (€)

935,284 €Ascended22 % *

Profit before tax (€)

912,567 €Ascended43 % *

Net Profit (€)

752,671 €Ascended42 % *

Profit per employee (€)

32,262 €Ascended31 % *

Total profitability (%)

12.00 %Descended-9.71 % *

Net profitability (%)

3.45 %Ascended6.81 % *

Equity (€)

1,835,713 €Ascended70 % *

Amounts Payable And Liabilities (€)

4,375,007 €Ascended127 % *

Non-current Assets (€)

35,460 €Ascended8 % *

CurrentAssets (€)

6,332,559 €Ascended106 % *

*over the last year starting selected period